Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin in South Asian Hypercholesterolemia
NCT00654225Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2002
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by AstraZeneca. Primary endpoint: Low Density Lipoprotein Cholesterol Levels at 6 weeks. Started Oct 2002; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00654225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654225.